New brain scan sheds light on Parkinson's and aging
NCT ID NCT07569120
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study uses advanced PET/MRI scanning to examine the noradrenaline system in the brains of 165 healthy adults and people with Parkinson's disease. Participants receive a radioactive tracer that binds to specific receptors, allowing researchers to see how this system changes with age and disease. The goal is to link these brain changes to thinking, memory, and movement abilities.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
[11C]ORM-13070 (a radioactive tracer for PET scans)
What this could lead to
If successful, this could reveal how the noradrenaline system changes with age and in Parkinson's, potentially guiding future treatments for cognitive and motor symptoms.
What could go wrong
This is an observational imaging study, not a treatment trial. It is early-stage and may not directly lead to new therapies. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY AGING AND PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Neurologique Pierre Wertheimer - Service de Neurologie
Bron, 69500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact